These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 15382222)
1. Evolving strategies to prevent HBV recurrence. Roche B; Samuel D Liver Transpl; 2004 Oct; 10(10 Suppl 2):S74-85. PubMed ID: 15382222 [TBL] [Abstract][Full Text] [Related]
2. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B: progress in the last 15 years. Villamil FG Liver Transpl; 2002 Oct; 8(10 Suppl 1):S59-66. PubMed ID: 12362301 [TBL] [Abstract][Full Text] [Related]
4. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation. Karademir S; Astarcioğlu H; Akarsu M; Ozkardesler S; Ozzeybek D; Sayiner A; Akan M; Tankurt E; Astarcioğlu I Transplant Proc; 2006 Mar; 38(2):579-83. PubMed ID: 16549180 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Cholongitas E; Goulis J; Akriviadis E; Papatheodoridis GV Liver Transpl; 2011 Oct; 17(10):1176-90. PubMed ID: 21656655 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin. Neff GW; Kemmer N; Kaiser TE; Zacharias VC; Alonzo M; Thomas M; Buell J Dig Dis Sci; 2007 Oct; 52(10):2497-500. PubMed ID: 17404847 [TBL] [Abstract][Full Text] [Related]
8. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Angus PW; Patterson SJ; Strasser SI; McCaughan GW; Gane E Hepatology; 2008 Nov; 48(5):1460-6. PubMed ID: 18925641 [TBL] [Abstract][Full Text] [Related]
9. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028 [TBL] [Abstract][Full Text] [Related]
10. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation. Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751 [TBL] [Abstract][Full Text] [Related]
11. Evolving experience of hepatitis B virus prophylaxis in liver transplantation. Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458 [TBL] [Abstract][Full Text] [Related]
12. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Marzano A; Lampertico P; Mazzaferro V; Carenzi S; Vigano M; Romito R; Pulvirenti A; Franchello A; Colombo M; Salizzoni M; Rizzetto M Liver Transpl; 2005 May; 11(5):532-8. PubMed ID: 15838891 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Yao FY; Osorio RW; Roberts JP; Poordad FF; Briceno MN; Garcia-Kennedy R; Gish RR Liver Transpl Surg; 1999 Nov; 5(6):491-6. PubMed ID: 10545536 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269 [TBL] [Abstract][Full Text] [Related]
16. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164 [TBL] [Abstract][Full Text] [Related]
17. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Katz LH; Tur-Kaspa R; Guy DG; Paul M Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Dan YY; Wai CT; Yeoh KG; Lim SG Liver Transpl; 2006 May; 12(5):736-46. PubMed ID: 16628682 [TBL] [Abstract][Full Text] [Related]
19. Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues. Patterson SJ; Angus PW Curr Opin Organ Transplant; 2009 Jun; 14(3):225-30. PubMed ID: 19373086 [TBL] [Abstract][Full Text] [Related]
20. Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin. Lo CM; Cheung ST; Ng IO; Liu CL; Lai CL; Fan ST Liver Transpl; 2004 Apr; 10(4):557-63. PubMed ID: 15048802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]